NRIX
Price
$16.13
Change
-$0.66 (-3.93%)
Updated
Feb 4, 03:07 PM (EDT)
Capitalization
1.73B
69 days until earnings call
Intraday BUY SELL Signals
NTRB
Price
$4.24
Change
-$0.32 (-7.02%)
Updated
Feb 4, 02:54 PM (EDT)
Capitalization
55.4M
86 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRIX vs NTRB

Header iconNRIX vs NTRB Comparison
Open Charts NRIX vs NTRBBanner chart's image
Nurix Therapeutics
Price$16.13
Change-$0.66 (-3.93%)
Volume$100
Capitalization1.73B
Nutriband
Price$4.24
Change-$0.32 (-7.02%)
Volume$100
Capitalization55.4M
NRIX vs NTRB Comparison Chart in %
NRIX
Daily Signal:
Gain/Loss:
NTRB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NRIX vs. NTRB commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and NTRB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (NRIX: $16.79 vs. NTRB: $4.56)
Brand notoriety: NRIX and NTRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 77% vs. NTRB: 22%
Market capitalization -- NRIX: $1.73B vs. NTRB: $55.4M
NRIX [@Biotechnology] is valued at $1.73B. NTRB’s [@Biotechnology] market capitalization is $55.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 1 FA rating(s) are green whileNTRB’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 1 green, 4 red.
  • NTRB’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than NTRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 3 TA indicator(s) are bullish while NTRB’s TA Score has 3 bullish TA indicator(s).

  • NRIX’s TA Score: 3 bullish, 5 bearish.
  • NTRB’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both NRIX and NTRB are a bad buy in the short-term.

Price Growth

NRIX (@Biotechnology) experienced а -13.50% price change this week, while NTRB (@Biotechnology) price change was -8.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

NRIX is expected to report earnings on Apr 14, 2026.

NTRB is expected to report earnings on May 01, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($1.73B) has a higher market cap than NTRB($55.4M). NTRB YTD gains are higher at: 0.441 vs. NRIX (-11.492). NTRB has higher annual earnings (EBITDA): -12.53M vs. NRIX (-248.7M). NRIX has more cash in the bank: 429M vs. NTRB (5.31M). NTRB has less debt than NRIX: NTRB (258K) vs NRIX (56.5M). NRIX has higher revenues than NTRB: NRIX (83.7M) vs NTRB (2.28M).
NRIXNTRBNRIX / NTRB
Capitalization1.73B55.4M3,116%
EBITDA-248.7M-12.53M1,985%
Gain YTD-11.4920.441-2,609%
P/E RatioN/AN/A-
Revenue83.7M2.28M3,674%
Total Cash429M5.31M8,076%
Total Debt56.5M258K21,899%
FUNDAMENTALS RATINGS
NTRB: Fundamental Ratings
NTRB
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRIXNTRB
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signal:
Gain/Loss:
NTRB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GENSY42.611.26
+3.05%
Genus Plc
KNBWY15.120.03
+0.20%
Kirin Holdings Co., Ltd.
SEIGF14.86N/A
N/A
Semperit Ag Holding
FMOO63.96N/A
N/A
F&M Bancorp
REVFF0.54-0.03
-5.17%
REV Exploration Corp.

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-1.76%
KYMR - NRIX
66%
Loosely correlated
+2.12%
DNLI - NRIX
58%
Loosely correlated
-4.22%
IDYA - NRIX
58%
Loosely correlated
+0.50%
SYRE - NRIX
56%
Loosely correlated
+1.65%
XNCR - NRIX
55%
Loosely correlated
-0.99%
More

NTRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRB has been loosely correlated with ABSI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRB jumps, then ABSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRB
1D Price
Change %
NTRB100%
-2.77%
ABSI - NTRB
34%
Loosely correlated
+2.32%
JSPR - NTRB
32%
Poorly correlated
-2.04%
VRAX - NTRB
31%
Poorly correlated
-1.84%
NRIX - NTRB
30%
Poorly correlated
-1.76%
KYMR - NTRB
29%
Poorly correlated
+2.12%
More